Company: SMNR
Filing Date: 2025-08-22
Form Type: DEFA14A
Source: 0001213900-25-079507
Chunk: 32

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: DEFA14A
Chunk 32
---
 have been no changes in the internal control over financial reporting (as such term is defined in the 1934 Act) of Denali that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of Denali.

(l) Transactions With Affiliates and Employees. Except as set forth in the SEC Documents, none of the officers or directors of Denali and, to the knowledge of Denali, none of the employees of Denali is presently a party to any transaction with Denali (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of Denali, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of Denali and (iii) other employee benefits, including stock option agreements under any stock option plan of Denali.

<div align='center'>17</div>

(m) Capitalization. The capitalization of Denali as of June 30, 2025 is as set forth in the SEC Documents, which includes the number of Class A ordinary shares of Denali owned beneficially, and of record, by affiliates of Denali as of June 30, 2025. Denali has not issued any capital stock since June 30, 2025 through the date of this Agreement. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Denali Transaction Documents. Except as disclosed in the SEC Documents, there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any share capital of Denali, or contracts, commitments, understandings or arrangements by which Denali is or may become bound to issue additional share capital of Denali. Denali does not have any stock appreciation rights or “phant